124 related articles for article (PubMed ID: 15114428)
1. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille JF; Sailler L; Dedieu G; Salvayre R; Thouvenot JP; Massip P; Montastruc JL
Eur J Clin Pharmacol; 2004 Jun; 60(4):285-92. PubMed ID: 15114428
[TBL] [Abstract][Full Text] [Related]
2. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.
Tavassoli N; Duchayne E; Sadaba B; Desboeuf K; Sommet A; Lapeyre-Mestre M; Muoz MJ; Sie P; Honorato J; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2007 Mar; 63(3):221-8. PubMed ID: 17225990
[TBL] [Abstract][Full Text] [Related]
3. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus JP; Valdiguié P; Montastruc JL
Br J Clin Pharmacol; 2000 Nov; 50(5):479-84. PubMed ID: 11069443
[TBL] [Abstract][Full Text] [Related]
4. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients.
Zhao A; Guo D; Zhu M; Gao A; Li P; Fu A
Eur J Clin Pharmacol; 2024 Jun; 80(6):911-918. PubMed ID: 38441574
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.
Chan SL; Tham MY; Tan SH; Loke C; Foo B; Fan Y; Ang PS; Brunham LR; Sung C
Clin Pharmacol Ther; 2017 May; 101(5):667-674. PubMed ID: 27706800
[TBL] [Abstract][Full Text] [Related]
6. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
7. Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.
Drobny M; Pullmann R; Odalos I; Skerenova M; Saniova B
Neuro Endocrinol Lett; 2014; 35(2):123-8. PubMed ID: 24878976
[TBL] [Abstract][Full Text] [Related]
8. Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Madeddu G; De Socio GV; Ricci E; Quirino T; Orofino G; Carenzi L; Franzetti M; Parruti G; Martinelli C; Vichi F; Penco G; Dentone C; Celesia BM; Maggi P; Libertone R; Bagella P; Di Biagio A; Bonfanti P;
Int J Antimicrob Agents; 2015 Mar; 45(3):289-94. PubMed ID: 25476452
[TBL] [Abstract][Full Text] [Related]
9. [Hospital readmission induced by adverse drug reaction: a pilot study in a post-emergency unit of a French university hospital].
Chayé H; Bernard M; Tubéry M; Rousseau V; Ecoiffier M; Montastruc JL; Bagheri H
Rev Med Interne; 2015 Jul; 36(7):450-6. PubMed ID: 25604839
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
11. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
12. [Muscular involvement and fibrates. Analysis of databanks of the French System of Pharmacovigilance].
Lavarenne J; Poinas-Caillaud H
Therapie; 1991; 46(5):347-9. PubMed ID: 1754976
[TBL] [Abstract][Full Text] [Related]
13. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.
Hauviller L; Eyvrard F; Garnault V; Rousseau V; Molinier L; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2016 May; 72(5):631-9. PubMed ID: 26884320
[TBL] [Abstract][Full Text] [Related]
14. Muscle toxicity with statins.
Hedenmalm K; Alvan G; Ohagen P; Dahl ML
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.
Tegeder I; Levy M; Muth-Selbach U; Oelkers R; Neumann F; Dormann H; Azaz-Livshits T; Criegee-Rieck M; Schneider HT; Hahn E; Brune K; Geisslinger G
Br J Clin Pharmacol; 1999 May; 47(5):557-64. PubMed ID: 10336581
[TBL] [Abstract][Full Text] [Related]
16. [Muscle problems due to statins: underestimated].
Janssen SP; Smulders YM; Gerdes VE; Visseren FL
Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
18. [Myotoxicity and rhabdomyolisis due to statins].
Banga JD
Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
[TBL] [Abstract][Full Text] [Related]
19. Development of a detection algorithm for statin-induced myopathy using electronic medical records.
Sai K; Hanatani T; Azuma Y; Segawa K; Tohkin M; Omatsu H; Makimoto H; Hirai M; Saito Y
J Clin Pharm Ther; 2013 Jun; 38(3):230-5. PubMed ID: 23530940
[TBL] [Abstract][Full Text] [Related]
20. Anti-infectives-induced adverse drug reactions in hospitalized patients.
Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
